Functional neuroanatomy of action selection in schizophrenia
dc.contributor.advisor
Willshaw, David
en
dc.contributor.advisor
Lawrie, Stephen
en
dc.contributor.author
Romaniuk, Liana
en
dc.contributor.sponsor
Medical Research Council (MRC)
en
dc.date.accessioned
2012-01-19T13:48:34Z
dc.date.available
2012-01-19T13:48:34Z
dc.date.issued
2011-11-24
dc.description.abstract
Schizophrenia remains an enigmatic disorder with unclear neuropathology. Recent advances
in neuroimaging and genetic research suggest alterations in glutamate-dopamine interactions
adversely affecting synaptic plasticity both intracortically and subcortically. Relating these
changes to the manifestation of symptoms presents a great challenge, requiring a constrained
framework to capture the most salient elements. Here, a biologically-grounded computational
model of basal ganglia-mediated action selection was used to explore two pathological processes
that hypothetically underpin schizophrenia. These were a drop in the efficiency of cortical
transmission, reducing both the signal-to-noise ratio (SNR) and overall activity levels; and
an excessive compensatory upregulation of subcortical dopamine release. It was proposed
that reduced cortical efficiency was the primary process, which led to a secondary disinhibition
of subcortical dopamine release within the striatum. This compensation was believed to
partly recover lost function, but could then induce disorganised-type symptoms - summarised
as selection ”Instability” - if it became too pronounced. This overcompensation was argued
to be countered by antipsychotic medication. The model’s validity was tested during an fMRI
(functional magnetic resonance imaging) study of 16 healthy volunteers, using a novel perceptual
decision-making task, and was found to provide a good account for pallidal activation.
Its account for striatum was developed and improved with a small number of principled model
modifications: the inclusion of fast spiking interneurons within striatum, and their inhibition
by the basal ganglia’s key regulatory nucleus, external globus pallidus. A key final addition
was the explicit modelling of dopaminergic midbrain, which is dynamically regulated by both
cortex and the basal ganglia. This enabled hypotheses concerning the effects of cortical inefficiency,
compensatory dopamine release and medication to be directly tested. The new
model was verified with a second set of 12 healthy controls. Its pathological predictions were
compared to data from 12 patients with schizophrenia. Model simulations suggested that Instability
went hand-in-hand with cortical inefficiency and secondary dopamine upregulation.
Patients with high Instability scores showed a loss of SNR within decision-related cortex (consistent
with cortical inefficiency); an exaggerated response to task demands within substantia
nigra (consistent with dopaminergic upregulation); and had an improved fit to simulated data
derived from increasingly cortically-inefficient models. Simulations representing the healthy
state provided a good account for patients’ motor putamen, but only cortically-inefficient simulations
representing the ill state provided a fit for ventral-anterior striatum. This fit improved
as the simulated model became more medicated (increased D2 receptor blockade). The relative improvement of this account correlated with patients’ medication dosage. In summary,
by distilling the hypothetical neuropathology of schizophrenia into two simplified umbrella processes,
and using a computational model to consider their effects within action selection, this
work has successfully related patients’ fMRI activation to particular symptomatology and antipsychotic
medication. This approach has the potential to improve patient care by enabling
a neurobiological appreciation of their current illness state, and tailoring their medication level
appropriately.
en
dc.identifier.uri
http://hdl.handle.net/1842/5758
dc.language.iso
en
dc.publisher
The University of Edinburgh
en
dc.relation.hasversion
Hall J, Romaniuk L, Mcintosh A, Steele JD, Johnstone EC, Lawrie S. Associative learning and the genetics of schizophrenia. Trends in Neurosciences. 2009 May;.
en
dc.relation.hasversion
Romaniuk L, Honey GD, King JR, Whalley HC, McIntosh AM, Levita L, et al. Midbrain Activation During Pavlovian Conditioning and Delusional Symptoms in Schizophrenia. Arch Gen Psychiatry. 2010 Nov;67(12):1246–1254.
en
dc.relation.hasversion
Hall J, Whalley HC, McKirdy JW, Romaniuk L, McGonigle D, McIntosh AM, et al. Overactivation of fear systems to neutral faces in schizophrenia. Biol Psychiatry. 2008 Jul;64(1):70–3. Notes Superb.
en
dc.subject
Schizophrenia
en
dc.subject
fMRI
en
dc.subject
computational modelling
en
dc.subject
basal ganglia
en
dc.subject
frontal cortex
en
dc.subject
action selection
en
dc.subject
decision making
en
dc.title
Functional neuroanatomy of action selection in schizophrenia
en
dc.type
Thesis or Dissertation
en
dc.type.qualificationlevel
Doctoral
en
dc.type.qualificationname
PhD Doctor of Philosophy
en
This item appears in the following Collection(s)

